Pharmacological induction of MHC-I expression in tumor cells revitalizes T cell antitumor immunity
Antigen presentation by major histocompatibility complex class I (MHC-I) is crucial for T cell–mediated killing, and aberrant surface MHC-I expression is tightly associated with immune evasion. To address MHC-I downregulation, we conducted a high-throughput flow cytometry screen, identifying bleomyc...
| Published in: | JCI Insight |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
American Society for Clinical investigation
2024-09-01
|
| Subjects: | |
| Online Access: | https://doi.org/10.1172/jci.insight.177788 |
